Study defines small-cell lung cancer subtypes and distinct therapeutic vulnerabilities for each type
COVID-19 model reveals key role for innate immunity in controlling viral load
21 January 2021Kenya says it has detected S. Africa COVID-19 strain
21 January 2021Study defines small-cell lung cancer subtypes and distinct therapeutic vulnerabilities for each type
Researchers from The University of Texas MD Anderson Cancer Center have developed the first comprehensive framework to classify small-cell lung cancer (SCLC) into four unique subtypes, based on gene expression, and have identified potential therapeutic targets for each type in a study published today in Cancer Cell.
